Condition
Intensive Care Neuropathy
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03753412Recruiting
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
NCT07167121Recruiting
Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months After ICU Discharge
NCT03714399Completed
Muscle Recovery Following Aortic Surgery Induced ICUAW.
NCT05053724Not ApplicableCompleted
Efficacy of the "Start to Move" Protocol on Functionality, Delirium and Acquired Weakness in ICU
NCT02474797Not ApplicableCompleted
Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With Sepsis
Showing all 5 trials